Cell Line Genetics

NEW YORK (GenomeWeb News) – Agilent Technologies today said it will collaborate with Cell Line Genetics to develop high-throughput, genomic characterization workflows for confirming and monitoring the integrity of cell lines for translational and regenerative medicine research.

This story has been updated to include additional comments from Ambry Genetics and Sigma-Aldrich.
By Justin Petrone

Ambry's StemArray is manufactured by Roche NimbleGen and enables researchers studying stem cells to detect genomic abnormalities that would ordinarily be missed by low-resolution karyotyping.

CLG will sell the StemArray products and services to its current customers and other companies and research institutions.

Around the Regions

Premium

Maryland Biotechnology Investment Incentive Tax Credit, Maryland Stem Cell Research Fund, Washington State Life Sciences Discovery Fund, California Institute for Regenerative Medicine, Sanford Consortium for Regenerative Medicine, Missouri Life-Sci/Tech Tax Credits, Wisconsin Technology Venture Fund, New Jersey Edison Innovation Fund, University City Science Center QED

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.